abiraterone krka
krka, d.d., novo mesto - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron acetat - prostatične neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
androcur 100 mg tablete
bayer d.o.o. - ciproteronacetat - tableta - ciproteronacetat 100 mg / 1 tableta - ciproteron
androcur 50 mg tablete
bayer d.o.o. - ciproteronacetat - tableta - ciproteronacetat 50 mg / 1 tableta - ciproteron
abiraterone accord
accord healthcare s.l.u. - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
diane 2 mg/0,035 mg obložene tablete
bayer d.o.o. - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.
bellune 2 mg/0,035 mg obložene tablete
pliva ljubljana d.o.o., ljubljana - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
bellune 2 mg/0,035 mg obložene tablete
pliva ljubljana d.o.o., ljubljana - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
climen obložene tablete
bayer pharma ag - estradiolvalerat; ciproteronacetat - obložena tableta - estradiolvalerat 2 mg / 1 tableta ciproteronacetat1 mg / 1 tableta; ciproteronacetat 1 mg / 1 tableta - ciproteron in estrogen